A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS
Conditions: Multiple Sclerosis; Spasticity, Muscle Interventions: Drug: Arbaclofen; Drug: Placebo Sponsor: Osmotica Pharmaceutical US LLC Not yet recruiting - verified September 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Study